Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- 11 March 2020
- journal article
- research article
- Published by Elsevier BV in Annals of Oncology
- Vol. 31 (6), 697-712
- https://doi.org/10.1016/j.annonc.2020.02.018
Abstract
No abstract availableKeywords
This publication has 113 references indexed in Scilit:
- The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPABlood, 2013
- Curability of Patients With Acute Myeloid Leukemia Who Did Not Undergo Transplantation in First RemissionJournal of Clinical Oncology, 2013
- Sense and nonsense of high-dose cytarabine for acute myeloid leukemiaBlood, 2013
- EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytesLeukemia, 2012
- How I treat extramedullary acute myeloid leukemiaBlood, 2011
- Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomesThe Lancet, 2010
- Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosisCancer, 2010
- Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete RemissionJAMA, 2009
- Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working PartyJournal of Clinical Oncology, 2007
- Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 2001